Literature DB >> 24134306

Voices from the Hilo Women's Health Study: talking story about menopause.

Lynn A Morrison1, Daniel E Brown, Lynnette L Sievert, Angela Reza, Nichole Rahberg, Phoebe Mills, Amber Goodloe.   

Abstract

Our purpose in conducting this qualitative study was to examine how a multiethnic sample of women living in Hilo, Hawai'i, describe menopause. Interviews were conducted with 185 pre-, peri-, and post-menopausal women aged 45 to 55. We found that pre-menopausal women felt anxious compared with peri- and post-menopausal women's more affirmative attitudes of increasing confidence and freedom in this new cycle of life. A dominant theme was the construction of a post-menstrual identity. Peri-and post-menopausal women's attitudes were not biomedically oriented. Local culture and the island lifestyle may provide a positive atmosphere for women going through menopause.

Entities:  

Mesh:

Year:  2013        PMID: 24134306      PMCID: PMC3925469          DOI: 10.1080/07399332.2013.829067

Source DB:  PubMed          Journal:  Health Care Women Int        ISSN: 0739-9332


  33 in total

Review 1.  A feminist approach to research on menopausal symptom experience.

Authors:  Eun-Ok Im
Journal:  Fam Community Health       Date:  2007 Jan-Mar

2.  Menopausal women's positive experience of growing older.

Authors:  Lotte Hvas
Journal:  Maturitas       Date:  2006-01-04       Impact factor: 4.342

3.  Cross-cultural comparison of women's midlife symptom-reporting: a China study.

Authors:  Jeanne L Shea
Journal:  Cult Med Psychiatry       Date:  2006-09

4.  Women's attitude and perceptions towards menopause in different cultures. Cross-cultural and intra-cultural comparison of pre-menopausal and post-menopausal women in Germany and in Papua New Guinea.

Authors:  Ingrid Kowalcek; Doerte Rotte; Constanze Banz; Klaus Diedrich
Journal:  Maturitas       Date:  2005-07-16       Impact factor: 4.342

5.  Vasomotor symptoms among Japanese-American and European-American women living in Hilo, Hawaii.

Authors:  Lynnette Leidy Sievert; Lynn Morrison; Daniel E Brown; Angela M Reza
Journal:  Menopause       Date:  2007 Mar-Apr       Impact factor: 2.953

6.  Vasomotor symptom prevalence and language of menopause in Japan.

Authors:  Melissa K Melby
Journal:  Menopause       Date:  2005 May-Jun       Impact factor: 2.953

7.  Psychosocial, behavioral, and health factors related to menopause symptomatology.

Authors:  N E Avis; S L Crawford; S M McKinlay
Journal:  Womens Health       Date:  1997

8.  Women's trust in and use of information sources in the treatment of menopausal symptoms.

Authors:  Sally A Huston; Rebekah M Jackowski; Duane M Kirking
Journal:  Womens Health Issues       Date:  2009 Mar-Apr

Review 9.  Reporter sex and newspaper coverage of the adverse health effects of hormone therapy.

Authors:  David E Nelson; Nancy Signorielli
Journal:  Women Health       Date:  2007

10.  Exploring the discursive construction of menopause for Thai women.

Authors:  S Punyahotra; A Street
Journal:  Nurs Inq       Date:  1998-06       Impact factor: 2.393

View more
  4 in total

1.  Identifying self-care behaviors in middle-aged women: A qualitative study.

Authors:  Fereshteh Ghaljaei; Nasrin Rezaee; Alireza Salar
Journal:  Electron Physician       Date:  2017-11-25

2.  Understanding the Contextual Factors Affecting Women's Health in Sistan and Baluchestan Province in Iran: A Qualitative Study.

Authors:  Nasrin Rezaee; Alireza Salar; Fereshteh Ghaljaei; Naimeh Seyedfatem; Neda Rezaei
Journal:  Int J Community Based Nurs Midwifery       Date:  2017-10

3.  Experiencing menopause in the UK: The interrelated narratives of normality, distress, and transformation.

Authors:  Isabel de Salis; Amanda Owen-Smith; Jenny L Donovan; Debbie A Lawlor
Journal:  J Women Aging       Date:  2017-11-02

Review 4.  The Multiple Pharmacologic Functions and Mechanisms of Action of Guizhi Fuling Formulation.

Authors:  Jie Gao; Jianmei Yang; Zhiyuan Lu; Xianwen Dong; Ying Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-29       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.